BRCA1 and non-small cell lung carcinoma: Somatic pathogenic or likely pathogenic mutations in BRCA1/2 (p-BRCA) are found in approximately 2–3% of NSCLC cases, the majority of which are not associated with carriers of BRCA PVs.